Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-04-24, Stock:NVS, The news for the past five days is as follows:
2019-04-16: NEWS1: Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran.NEWS2: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.NEWS3: Allergan Falls as Supreme Court Dismisses Restasis Litigation.NEWS4: Allergan Falls as Supreme Court Dismisses Restasis Litigation.NEWS5: Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA.NEWS6: Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA.NEWS7: Marijuana ETF Down 9% in Past Month: Time to Enter the Space?.NEWS8: Allergan Falls as Supreme Court Dismisses Restasis Litigation.NEWS9: Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA.NEWS10: The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives.
2019-04-17: NEWS1: Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted.NEWS2: Health Care Sector Update for 04/17/2019: IONS,NVS,MASI,TXMD,ONCS.NEWS3: Health Care Sector Update for 04/17/2019: IONS,NVS,MASI,TXMD,ONCS.NEWS4: Here's Why Ionis Pharmaceuticals Slumped Today.NEWS5: Here's Why Ionis Pharmaceuticals Slumped Today.NEWS6: Here&apos;s Why Ionis Pharmaceuticals Slumped Today.NEWS7: Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted.NEWS8: Marijuana ETF Down 9% in Past Month: Time to Enter the Space?.NEWS9: Marijuana ETF Down 9% in Past Month: Time to Enter the Space?.NEWS10: The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO.NEWS11: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.NEWS12: Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales.NEWS13: Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran.NEWS14: Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran.
2019-04-18: NEWS1: Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs.NEWS2: Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs.NEWS3: Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs.
2019-04-22: NEWS1: A Second Baby Died In A Gene Therapy Study — Slugging This Biotech Stock.NEWS2: Pfizer Stock Suffers From an Underappreciated Drugs Pipeline.NEWS3: Pfizer Stock Suffers From an Underappreciated Drugs Pipeline.NEWS4: Pfizer Stock Suffers From an Underappreciated Drugs Pipeline.
2019-04-23: NEWS1: Medicare offers to partially raise payment for cancer CAR-Ts.NEWS2: Kidney-Cancer Market: Good for Patients, Hard for Investors.NEWS3: Kidney-Cancer Market: Good for Patients, Hard for Investors.NEWS4: 2 Best Biotech Buyout Plays.NEWS5: 2 Best Biotech Buyout Plays.NEWS6: Health-care earnings: ‘Medicare for all’ looms large.NEWS7: Pre-Market Most Active for Apr 23, 2019 :  TWTR, STNE, NVS, BP, SNAP, LYFT, KO, STM, SQQQ, AMD, TSLA, AMRN.NEWS8: Pre-Market Most Active for Apr 23, 2019 :  TWTR, STNE, NVS, BP, SNAP, LYFT, KO, STM, SQQQ, AMD, TSLA, AMRN.NEWS9: Validea Peter Lynch Strategy Daily Upgrade Report - 4/23/2019.NEWS10: Validea Peter Lynch Strategy Daily Upgrade Report - 4/23/2019.NEWS11: Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 4/23/2019.NEWS12: Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 4/23/2019.

Answer: Rise